Pages that link to "Q36181289"

The following pages link to Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies (Q36181289):

Displaying 13 items.

• Protein misfolding in neurodegenerative diseases: implications and strategies (Q37697832) (← links)
• A Metal-Free Method for Producing MRI Contrast at Amyloid-β. (Q46451313) (← links)
• Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier (Q48222289) (← links)
• Targeting microglia for the treatment of Alzheimer's Disease. (Q53376999) (← links)
• Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease. (Q54982684) (← links)
• SAR228810: an antibody for protofibrillar amyloid β peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA) (Q59802832) (← links)
• Antibody-mediated clearance of tau in primary mouse microglial cultures requires Fcγ-receptor binding and functional lysosomes (Q64091044) (← links)
• Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration (Q90477691) (← links)
• A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease (Q90893924) (← links)
• A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer's Disease (Q91723176) (← links)
• Harnessing MerTK agonism for targeted therapeutics (Q92090357) (← links)
• Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer's-like mice (Q92605430) (← links)
• Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life (Q102075576) (← links)